RxDoctor Payments Data

Stacy Lessman, MD

Family Medicine · Waco, TXNPI 1821095316

Payments from drug & device makers

$697in general payments, 2019–2025

Across 39 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$172
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$135
  • Novo Nordisk$90
  • Dexcom, Inc.$88
  • GSK$53
  • Merck$52
  • plus $108 from 3 others

What the payments were for

  • Food & beverage$697100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$697 in reported general payments places this provider in the 55th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$6,437
Medicare patients
58
Services billed
466

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide81$102,985
EliquisApixaban34$40,218
RybelsusSemaglutide30$37,778
JanuviaSitagliptin Phosphate25$32,011
MounjaroTirzepatide28$31,894
Breo ElliptaFluticasone/Vilanterol32$31,000
TrulicityDulaglutide23$28,728
XareltoRivaroxaban14$19,180
LinzessLinaclotide17$18,243
Incruse ElliptaUmeclidinium Bromide12$9,354
Albuterol Sulfate HfaAlbuterol Sulfate266$7,658
SymbicortBudesonide/Formoterol Fumarate20$6,549
Lantus SolostarInsulin Glargine,hum.Rec.Anlog55$6,326
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen195$5,678
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog15$5,454

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$90$140,762111 claims
Lilly USA, LLCMounjaro, Trulicity$172$60,62251 claims
GSKBreo Ellipta, Incruse Ellipta$53$40,35444 claims
PfizerEliquis$15$40,21834 claims
MerckJanuvia$52$32,01125 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Waco

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →